全文获取类型
收费全文 | 19978篇 |
免费 | 1263篇 |
国内免费 | 906篇 |
专业分类
耳鼻咽喉 | 81篇 |
儿科学 | 471篇 |
妇产科学 | 305篇 |
基础医学 | 3758篇 |
口腔科学 | 484篇 |
临床医学 | 1539篇 |
内科学 | 2907篇 |
皮肤病学 | 429篇 |
神经病学 | 1491篇 |
特种医学 | 369篇 |
外国民族医学 | 6篇 |
外科学 | 1310篇 |
综合类 | 3294篇 |
现状与发展 | 1篇 |
预防医学 | 958篇 |
眼科学 | 254篇 |
药学 | 2474篇 |
2篇 | |
中国医学 | 894篇 |
肿瘤学 | 1120篇 |
出版年
2024年 | 33篇 |
2023年 | 179篇 |
2022年 | 434篇 |
2021年 | 557篇 |
2020年 | 565篇 |
2019年 | 531篇 |
2018年 | 571篇 |
2017年 | 601篇 |
2016年 | 562篇 |
2015年 | 660篇 |
2014年 | 1099篇 |
2013年 | 1420篇 |
2012年 | 1070篇 |
2011年 | 1326篇 |
2010年 | 983篇 |
2009年 | 1003篇 |
2008年 | 1045篇 |
2007年 | 1116篇 |
2006年 | 1033篇 |
2005年 | 933篇 |
2004年 | 828篇 |
2003年 | 727篇 |
2002年 | 557篇 |
2001年 | 503篇 |
2000年 | 452篇 |
1999年 | 330篇 |
1998年 | 381篇 |
1997年 | 333篇 |
1996年 | 342篇 |
1995年 | 328篇 |
1994年 | 226篇 |
1993年 | 178篇 |
1992年 | 119篇 |
1991年 | 128篇 |
1990年 | 104篇 |
1989年 | 70篇 |
1988年 | 63篇 |
1987年 | 49篇 |
1986年 | 38篇 |
1985年 | 107篇 |
1984年 | 93篇 |
1983年 | 59篇 |
1982年 | 80篇 |
1981年 | 68篇 |
1980年 | 50篇 |
1979年 | 39篇 |
1978年 | 29篇 |
1977年 | 26篇 |
1976年 | 28篇 |
1975年 | 33篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
骨感染病人TNF-α、IL-6和C反应蛋白的检测及临床意义 总被引:1,自引:0,他引:1
①目的 探讨骨感染病人肿瘤坏死因子α(TNF α)、白细胞介素 6 (IL 6 )和C反应蛋白 (CRP)水平的变化及意义。②方法 采用双抗体夹心ELISA法测定 30例骨感染病人及 2 5例正常人的血清TNF α、IL 6水平 ,采用散射比浊法测定CRP水平。③结果 骨感染病人血清中TNF α、IL 6及CRP含量均处于高水平状态 ,与健康人比较 ,差异有显著性 (t=2 .2 6~ 10 .6 7,P <0 .0 5、0 .0 1)。④结论 TNF α、IL 6及CRP是预测骨感染病人病情危重的重要指标之一 ,对临床有一定指导意义 相似文献
63.
Zhang Gui-mei Hao Tian-ling Yang Yu-zhen Feng Zuo-hua Jiang Zhi-yao Zhou Bin Zhang Hui 《华中科技大学学报(医学英德文版)》1992,12(3):150-153
Summary Effects of Chinese Medicinal Preparation “Re Du Qing” (RDQ) on the activation, proliferation and membrane fluidity of T lymphocytes
from human peripheral blood Were studied by means of3H-TdR incorporation and DPH fluorescence polarization. The results showed that “RDQ” can:1) significantly inhibit the activation
of T lymphocytes; 2) restrain the proliferation of activated T lymphoblasts in the presence of exogenous interleukin-2 (IL-2);
and 3) increase the membrane fluidity of T lymphocytes and antagonize the decreased fluidity of lymphocyte membrane mediated
by Con A or PHA. The functional abnormalities of T lymphocytes in some autoimmune diseases such as arthritis and the usefulness
of RDQ in the treatment of these diseases were also discussed. 相似文献
64.
Fentanyl and the interleukin-6 response to surgery 总被引:12,自引:0,他引:12
It has been suggested that large doses of opioids may suppress the interleukin-6 response to surgery. We examined the effects of the supplementation of inhalational anaesthesia with either 3 or 15 μg.kg−1 fentanyl on the circulating interleukin-6, interleukin-8, C-reactive protein, cortisol and glucose concentrations in 16 patients undergoing pelvic surgery. In both groups, surgery evoked the expected glucose, cortisol and interleukin-6 response but no increase in interleukin-8 was detected. There were no significant differences between the two groups. We conclude that the supplementation of inhalational anaesthesia with conventional doses of opioids does not modify the cytokine response to surgery. 相似文献
65.
66.
Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis 总被引:4,自引:0,他引:4
Summary Levels of soluble IL-2 receptors, IL-6, soluble CD23, soluble CD14 and ECP (eosinophilic cationic protein) were measured as markers of T-cell, B-cell, monocyte and eosinophilic leucocyte activation in 26 patients with atopic dermatitis (AD) on admission to (A) and at discharge from (D) the Department of Dermatology in Zurich. The serum levels of sIL-2R, IL-6, sCD23, sCD14 and ECP were significantly elevated in AD patients in comparison with the normal values of healthy donors. A significant decrease in sIL-2R (p=0.0093) and in sCD14 (p=0.0134) levels was demonstrated between A and D, correlating with the improvement in the skin intensity score (SIS). In addition, a significant correlation of the sCD14 levels and the SIS at A was demonstrated (p=0.0415). These results also incriminate monocytes in the pathogenesis of AD, indicating that, besides sIL-2R and ECP, SCD14 could also be a possible marker for the disease activity. 相似文献
67.
Interleukin–2 and hyperthermia have been used individually to treat a variety of tumors in both experimental and human trials. Combined adoptive immunotherapy and hyperthermia is an exciting new line of investigation. Previous work in our laboratory has shown that combined local hyperthermia and rIL-2 therapy can significantly decrease the rate of tumor growth. In this study, we investigated the effect of combined whole-body hyperthermia (WBHT) and rIL-2 on the growth of subcutaneous MCA-105 murine tumors in C57BL/6 mice. Treatment of both microscopic (day 3) and macroscopic (day 10) tumors was evaluated. In the treatment of microscopic tumors, animals received either no treatment; rIL-2 (3 × 105 IU ip tid) on days 3–7; plus WBHT(41°C for 30 min) on days 3, 5, and 7; or WBHT only on days 3, 5, and 7. In treating macroscopic tumors, animals received either no treatment; rIL-2 on days 10–14; plus WBHT on days 10, 12, and 14; or WBHT only on days 10, 12, and 14. While combined treatment and WBHT alone had no significant effect on the growth of microscopic tumors, combined IL-2 and WBHT significantly reduced the rate of tumor growth of macroscopic tumors. These results suggest that the tumor microenvironment plays a critical role in combined WBHT and rIL-2 therapy, and may be due to effects of WBHT on the tumor vasculature. © 1993 Wiley-Liss, Inc. 相似文献
68.
E. SCHÜTZ M. LUY-KALTEFLEITER M. KALTEFLEITER M. BURDELSKI† B. RINGE V. W. ARMSTRONG M. OELLERICH 《European journal of clinical investigation》1996,26(10):907-916
Abstract. Post-transplant assessment of early graft function has become an essential part of monitoring, especially when deciding on retransplantation. If primary non-function is indicated, retransplantation is inevitable; early graft dysfunction may be related to subsequent complications. In a prospective study in 84 patients after orthotopic liver transplantation (OLT) we measured aspartate aminotransferase (AST), alanine aminotransferase (ALT), glutamate dehydrogenase (GLDH), bilirubin (BIL), prothrombin time, MEGX formation, hyaluronic acid (HA) and soluble interleukin-2 receptor (sIL-2R) concentrations during the first 2 postoperative weeks; graft outcome was followed over 4 months. The aim of this study was to determine whether graft survival could be predicted by such variables early after OLT. Compared with patients with stable graft function (n= 25), patients with post-transplant icteric cholestasis (n= 30) exhibited no difference in graft survival, despite a decrease in MEGX formation to a nadir median of 12 μgL-1 on day 10. Patients with rejection (n= 8) and septicaemia (n= 6) showed a marked decrease in MEGX values and an increase in HA and sIL-2R concentrations between postoperative days 3 and 7. Patients with primary non-function (PNF; n= 5) were characterized by strongly reduced MEGX formation (median 4 μgL) and increased HA values (median 2300 μgL-1) on day 3 after OLT. A total of 24/84 grafts were lost within 120 days. In a survival analysis using the Cox proportional hazards regression, HA and MEGX values on day 1 were the only independent variables entering the model that showed an adequate prognostic sensitivity. At cut-off points of 22 μgL-1 (MEGX) and 730 μgL-1 (HA) the combined use of these parameters in a parallel approach yielded a sensitivity of 58% with a corresponding specificity of 95% for 120-day graft survival. These findings suggest that the inclusion of MEGX and HA in postoperative monitoring of OLT patients may be helpful in the early prediction of graft survival. 相似文献
69.
Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. 总被引:2,自引:0,他引:2
Andreas Fusshoeller Marcus Plail Bernd Grabensee Joerg Plum 《Nephrology, dialysis, transplantation》2004,19(8):2101-2106
BACKGROUND: In chronic ambulatory peritoneal dialysis, bicarbonate-buffered fluids, with their neutral pH and less advanced glycosylation end-products (AGE) and glucose degradation products (GDP), have better biocompatibility than conventional peritoneal dialysis (PD) solutions. That difference may be more beneficial in automated peritoneal dialysis (APD), due to its more frequent exchanges and longer contact times with fresh dialysate. We performed a prospective, randomized study in APD patients to compare the biocompatibility of conventional and bicarbonate/lactate-buffered PD fluids. METHODS: We randomized 14 APD patients to have APD with either conventional or bicarbonate/lactate-based fluids. After 6 months, both groups changed to the other solution. The overall observation period was 12 months. After 1 and 5 months and again after 7 and 11 months, phagocytotic and respiratory burst capacities of effluent peritoneal macrophages were determined. Plasma interleukin (IL)-6 and C-reactive protein (CRP) as well as effluent IL-6, CRP, transforming growth factor (TGF)-beta 1, AGE and CA125 concentrations were measured. Inflow pain was quantified using a patient questionnaire. RESULTS: Respiratory burst capacity remained unchanged and phagocytotic activity increased significantly during APD (P<0.001) with the bicarbonate/lactate fluid. Effluent IL-6 release was significantly lower than with the lactate fluid (P<0.05). While in the effluent TGF-beta 1 was unaffected, AGE concentration was lower after bicarbonate/lactate treatment (P<0.05). Effluent CA125 concentration, an indicator of mesothelial cell integrity, was higher (P<0.05) in neutral effluents. Finally, patients' inflow pain diminished (P = 0.05) when using the neutral fluid. CONCLUSIONS: The use of a neutral PD fluid in APD improved patients' inflow pain as well as biocompatibility parameters reflecting enhanced phagocytotic activity of peritoneal macrophages, reduced constitutive inflammatory stimulation (IL-6), reduced AGE accumulation in the peritoneal cavity and better preservation of the mesothelial cell integrity. From the biocompatibility point of view, a neutral fluid with low GDP content can be recommended as the primary choice for APD. 相似文献
70.
利多卡因对N-甲基-D-天冬氨酸抑制大鼠肾上腺嗜铬细胞瘤细胞增殖的影响 总被引:2,自引:0,他引:2
目的 观察利多卡因对 N-甲基-D-天冬氨酸(NMDA)抑制大鼠肾上腺嗜铬细胞瘤细胞(PC12细胞)增殖的影响。方法 将体外培养的 PC12细胞分为6组,分别采用正常不含药液的培养基(C组);含400μmol·L(-1)NMDA 的培养基(N组);NMDA 分别混合10μmol·L~(-1)(L_1组)、10~2μmol·L~(-1)(L_2组)、10~3μmol·L~(-1)(L_3组)以及10~4μmol·L~(-1)(L_4组)利多卡因的培养基培养5d,应用流式细胞仪测定细胞 DNA 相对含量,解析细胞周期,计算 S 期细胞荧光强度占受测细胞总荧光强度的百分数为 S期分数(SPF)和 S 期与 G_2期细胞荧光强度之和与 M 期细胞荧光强度的比值[(S G_2)/M]。结果 与C 组比较,N、L_1组 SPF 和(S G_2)/M 均降低(P<0.05),L_4组 SPF 降低(P<0.05),而 L_2及 L_3组 SPF和(S G_2)/M 差异无统计学意义(P>0.05)。与 N 组比较,L_2、L_3及 L_4组 SPF 和(S G_2)/M 升高(P<0.05),L_1组 SPF 升高(P<0.05),而(S G_2)/M 差异无统计学意义(P>0.05)。结论 NMDA 可以通过抑制 PC12细胞 DNA 合成而影响细胞的增殖活性,利多卡因能拮抗 NMDA 对 PC12细胞增殖的抑制作用。 相似文献